EMA begins assessment of Pfizer booster application
Pfizer has submitted an application for the Covid-19 vaccine Comirnaty as a booster shot in re-vaccination plans.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
The European Medicines Agency (EMA) is analyzing data from Pfizer, which is seeking approval for its Covid-19 vaccine Comirnaty for use as booster dose.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Danish government cancels vaccine production tender
For subscribers
Astrazeneca and EU settle missing vaccines case
For subscribers
.jpg&w=384&q=75)
